Harvard Medical School
25 Shattuck Street
Boston
Massachusetts
02115
United States
Tel: 617-432-1000
Website: http://www.hms.harvard.edu/
527 articles with Harvard Medical School
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Ariadne Labs Partners with Harvard Medical School Students to Develop Evidence-Based Everyday Activity Guidelines for COVID-19 Protection
4/30/2020
Newly released Safe Grocery Shopping Checklist provides guidance to ensure safety before, during and after trips to the grocery store; future guidelines will address handling mail, ordering takeout, using masks, and more [30-April-2020] BOSTON , April 30, 2020 /PRNewswire/ -- Ariadne Labs has partnered with the Harvard Medical School student group, HMS COVID-19
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
The study notes that about half of recent drug approvals were built on a single pivotal clinical trial. Typically, two pivotal, Phase III trials were the norm.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
The technique allows the researchers to engineer the virus shell to deliver the gene package to the exact cell type in the body they intend to treat.
-
New Harvard Medical School Study Finds Blue Cross Blue Shield of Massachusetts Alternative Quality Contract Slowed Spending, Improved Care Over 8 Years
7/17/2019
Blue Cross Blue Shield of Massachusetts' Alternative Quality Contract slowed the rate of medical spending growth by up to 12% while improving patient care over the course of eight years, Harvard Medical School researchers report in a landmark study published in the New England Journal of Medicine.
-
Reducing False Positive Results for Sepsis with Steripath Improves Economic and Clinical Outcomes, Study Reports
4/17/2019
Findings published in the Journal of Hospital Infection highlight the associated positive impacts of Magnolia Medical Technologies' novel Initial Specimen Diversion Device (ISDD)
-
Big data study identifies drugs that increase risk of psychosis in youth with ADHD
3/20/2019
Certain drugs prescribed to teens and young adults with ADHD increase their risk of psychosis, say researchers at McLean Hospital and Harvard Medical School.
-
In the wake of the scandal caused by a Chinese researcher’s use of CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, leading scientists called for a moratorium on heritable genome editing.
-
IBM Watson Health Invests in Research Collaborations with Leading Medical Centers to Advance the Application of AI to Health
2/13/2019
Initial projects focus on practical application of AI to improve care, enhance health team workflow, and better understand human-machine interactions
-
The idea of swallowing a needle seems like a very bad idea. But a research team at MIT has developed a capsule about the size of a blueberry that holds a tiny needle that, after being swallowed, injects insulin into the stomach.
-
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approach...
-
Readers' Picks: Top 10 Stories of 2018
12/28/2018
As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more. -
Harvard Medical School and Brigham and Women’s Hospital are leading the call to remove the papers from the lab of Dr. Piero Anversa, a pioneer in the field of cardiac research.
-
Hundreds of millions of dollars have been pledged by billionaires to advance scientific research.
-
The U.S. FDA approved Pfizer’s Lorbrena (lorlatinib) for ALK-positive metastatic non-small cell lung cancer (NSCLC) in patients whose disease hasn’t progressed on crizotinib and at least one other ALK inhibitor or for patients whose disease has progressed on alectinib or ceritinib as the first AL...
-
NHLBI Halts Heart Failure Study After Retracted Papers Raise Concern Over Controversial Stem Cell...
10/30/2018
In the wake of a significant number of journal articles being retracted due to falsified data, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, is halting a clinical trial that is testing an experimental stem cell therapy for heart patients. -
October 19 Research Roundup: Dementia, Frankenstein Proteins, and Epigenetic Sperm Changes
10/19/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
19 (at Least!) of TIME Magazine’s 50 Most Influential Healthcare People Have Biopharma Ties
10/19/2018
TIME Magazine came out with a list of the 50 most influential people in healthcare, dubbed The Health Care 50. A look through the list shows just how many ties and connections—as well as influence—this group has on the biopharma industry.